Literature DB >> 31004677

Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.

Adam M Hanif1, Rachel Shah1, Jiong Yan1, Jithin S Varghese2, Shivani A Patel3, Blaine E Cribbs1, Ghazala O'Keefe1, Andrew M Hendrick1, Jessica G Shantha1, G Baker Hubbard1, Purnima S Patel1, Prethy Rao1, Steven Yeh1, Nieraj Jain4.   

Abstract

Entities:  

Year:  2019        PMID： 31004677     DOI： 10.1016/j.ophtha.2019.04.024

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  12 in total

1.  Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort.

Authors:  Nieraj Jain; Alexa L Li; Yinxi Yu; Brian L VanderBeek
Journal:  Br J Ophthalmol       Date:  2019-11-06       Impact factor: 4.638

2.  Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.

Authors:  Rachel Shah; Joseph M Simonett; Riley J Lyons; Rajesh C Rao; Mark E Pennesi; Nieraj Jain
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

Review 3.  Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.

Authors:  Chirantan Mukhopadhyay; Timothy M Boyce; Karen M Gehrs; James C Folk; Robert F Mullins; Yi Luo; Karl Kreder; Elliott H Sohn
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2022 Mar-Apr 01

Review 4.  Fundus Autofluorescence and Clinical Applications.

Authors:  Cameron Pole; Hossein Ameri
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

5.  Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Authors:  Alyssa Gracely; Anne P Cameron
Journal:  Drugs Aging       Date:  2020-10-23       Impact factor: 3.923

6.  Pentosan associated retinal pigmentary changes: FDA's perspective on an emerging postmarketing safety finding.

Authors:  Allison Lardieri; Karen Konkel; Lynda McCulley; S Christopher Jones; David Moeny; Christine Nguyen; Catherine Sewell; Wiley Chambers; Adebola Ajao
Journal:  Int Urogynecol J       Date:  2021-09-10       Impact factor: 2.894

7.  PENTOSAN POLYSULFATE AND VISION: Findings from an International Survey of Exposed Individuals.

Authors:  Ogul E Uner; Megha K Shah; Nieraj Jain
Journal:  Retina       Date:  2021-07-01       Impact factor: 3.975

8.  Visual Function in Pentosan Polysulfate Sodium Maculopathy.

Authors:  Riley J Lyons; Judy Brower; Nieraj Jain
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

9.  Maculopathy Secondary to Pentosan Polysulfate Use: A Single-Center Experience.

Authors:  Neil S Kalbag; Nenita Maganti; Alice T Lyon; Rukhsana G Mirza
Journal:  Clin Ophthalmol       Date:  2021-02-11

10.  A case of pentosan polysulfate maculopathy originally diagnosed as stargardt disease.

Authors:  Robin A Vora; Amar P Patel; Sam S Yang; Ronald Melles
Journal:  Am J Ophthalmol Case Rep       Date:  2020-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.